Navigation Links
MU researcher placing eye implants in cats to help humans see

In "Star Trek: The Next Generation," Geordi La Forge is a blind character who can see through the assistance of special implants in his eyes. While the Star Trek character "lives" in the 24th century, people living in the 21st century may not have to wait that long for the illuminating technology.

Kristina Narfstrom, a University of Missouri-Columbia veterinary ophthalmologist, has been working with a microchip implant to help blind animals "see." According to Narfstrom, the preliminary results are promising.

"About one in 3,500 people worldwide is affected with a hereditary disease, retinitis pigmentosa, that causes the death of retinal cells and, eventually, blindness," Narfstrom said. "Our current study is aimed at determining safety issues in regard to the implants and to further develop surgical techniques. We also are examining the protection the implants might provide to the retinal cells that are dying due to disease progression with the hope that natural sight can be maintained much longer than would be possible in an untreated patient."

Narfstrom, the Ruth M. Kraeuchi-Missouri Professor in Veterinary Ophthalmology, is working primarily with Abyssinian and Persian cats that are affected with hereditary retinal blinding disease. The cat's eye is a good model to use for this type of research because it is very similar to a human eye in size and construction, so surgeons can use the same techniques and equipment. Cats also share many of the same eye diseases with humans. The Abyssinian cats that Narfstrom is working with typically start to lose their sight when they are around one or two years old and are completely blind by age four.

To date, Narfstrom has performed surgeries in severely visually impaired or blind cats. During the surgery, Narfstrom makes two small cuts into the sclera,

the outer wall of the eyeball. After removing the vitreous, which is the gelatinous fluid inside the back p
'"/>

Source:University of Missouri-Columbia


Page: 1 2

Related biology news :

1. U of M researcher examines newly emerging deadly disease
2. NYU researchers simulate molecular biological clock
3. Vital step in cellular migration described by UCSD medical researchers
4. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
5. UCSD researchers maintain stem cells without contaminated animal feeder layers
6. Why do insects stop breathing? To avoid damage from too much oxygen, say researchers
7. New protein discovered by Hebrew University researchers
8. First real-time view of developing neurons reveals surprises, say Stanford researchers
9. Agilent Technologies releases automated literature search tool for biology researchers
10. Self-assembled nano-sized probes allow Penn researchers to see tumors through flesh and skin
11. Yale researchers identify molecule for detecting parasitic infection in humans
Post Your Comments:
(Date:12/3/2009)Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, accord
(Date:12/3/2009)ALBUQUERQUE, N.M. Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many b
(Date:12/3/2009)Spanish researchers have measured CO2 levels for the past three years in the troposphere (lower atmosphere) over a sparsely inhabited rural area near Valladolid. The results, which are the first of th
Breaking Biology News(10 mins):Lifelong memories linked to stable nerve connections 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3CO2 levels rising in troposphere over rural areas 2Taking dex can improve high altitude exercise capacity in certain climbers 54225 1Taking dex can improve high altitude exercise capacity in certain climbers 54225 2Taking dex can improve high altitude exercise capacity in certain climbers 54225 3Health Insurance Provider Sites Attract Fewer U S Visitors as Unemployment Increases 54224 1Health Insurance Provider Sites Attract Fewer U S Visitors as Unemployment Increases 54224 2Health Insurance Provider Sites Attract Fewer U S Visitors as Unemployment Increases 54224 3World Stem Cell Summit to Be Held in Baltimore 13504 1World Stem Cell Summit to Be Held in Baltimore 13504 2
...es may prevent recovering drug abusers from relaps...ve discovered., The team, led by Professor Barry E... in rats by blocking a brain chemical receptor imp... drug-associated memories. Their research, which ...ported in the 13 August issue of The Journal of N...
...2 AUGUST 2008 -- More than 10,000 international sc...ill gather at the George R. Brown Convention Cente...test research and trends in energy, water resource... earth sciences, and related disciplines. , This ... that showcases the sciences of the sponsoring org...
...performance of different types of green roofs has ... Center at The University of Texas at Austin and s...re created equal. , Interest in vegetated roofs h...mes more important to property owners. Yet the stu...the green roofs varied greatly in capabilities suc...
Other Biology News:'Erasing' drug-associated memories may stop drug addiction relapses 2Scientists team up in Houston to tackle global challenges 2Scientists team up in Houston to tackle global challenges 3Scientists team up in Houston to tackle global challenges 4Green roofs differ in building cooling, water handling capabilities 2Green roofs differ in building cooling, water handling capabilities 3
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
(Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We
(Date:12/2/2009)QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today annou
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
....,(NasdaqGS: VARI) today announced that Garry W. R...q OMX 22nd Investor Program in London on Thursday,... A live webcast of the presentation will be publi...://www.varianinc.com . Go to http://www.varianin...ay will be available to the public,from Varian, In...
... marketing research,leader in pain, announces resu...g Company Survey". The top three most appreciated...ticals, according to the 100 pain clinic,physician... most noted for,their knowledgeable, respectful an...oucher plans, and their educational resources, as ...
...Innovations, LLC, a subsidiary of Wound Management...ished case demonstrating the efficacy of their adv... The case was presented in the,November/December ...ection,Diabetic Wound Care Management on the Leadi... #1: Using Combined Treatment Modalities for Succe...
Other Biology Technology:WWMR Announces Pain Clinic Physicians' Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals 2WWMR Announces Pain Clinic Physicians' Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals 3Wound Management Technologies, Inc. Announces a Published Case Study 2Wound Management Technologies, Inc. Announces a Published Case Study 3
T7 RNA Polymerase from Invitrogen
T7 RNA polymerase from Chimerx
Hexokinase/ Glucose-6-Phosphate Dehydrogenase from Roche Applied Science
RNase H from Roche Applied Science
Biology Products: